These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 11247247)

  • 1. [Immune preparation IRS-19 in the treatment of inflammation in the upper respiratory tracts].
    Gunchikov MV; Vinnikov AK
    Vestn Otorinolaringol; 2001; (1):40. PubMed ID: 11247247
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of a new immunostimulating bacterial lysate in the prophylaxis of acute lower respiratory tract infections. A randomised, open, controlled clinical trial.
    Rossi S; Tazza R
    Arzneimittelforschung; 2004; 54(1):50-6. PubMed ID: 14979609
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and treatment of upper respiratory tract infections with IRS-19 and polydex with phenylephrine].
    Luchikhin LA; Beliakova LV; Gurov AV
    Vestn Otorinolaringol; 2000; (4):54-7. PubMed ID: 11011582
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal vaccines for protection against respiratory and systemic bacterial infections.
    Oliveira ML; Arêas AP; Ho PL
    Expert Rev Vaccines; 2007 Jun; 6(3):419-29. PubMed ID: 17542756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications and results of immunostimulation with microbial products in diseases of the upper respiratory tract].
    Seropian E; Ionescu N; Andone C; Filip V
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(1):77-9. PubMed ID: 6454225
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M; Eckenberger HP
    Fortschr Med; 1992 Nov; 110(30):565-70. PubMed ID: 1468743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and efficacy of nasal application of CpG oligodeoxynucleotide as a mucosal adjuvant.
    Kodama S; Abe N; Hirano T; Suzuki M
    Laryngoscope; 2006 Feb; 116(2):331-5. PubMed ID: 16467729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Forced microbial stimulation in respiratory infections].
    Filip V; Brezeanu A; Ionescu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(4):369-72. PubMed ID: 2879341
    [No Abstract]   [Full Text] [Related]  

  • 11. The assessment of the therapeutic effectiveness of IRS-19 in allergic children with recurrent or chronic respiratory infections.
    Maciorkowska E; Kaczmarski M; Cudowska B; Stasiak-Barmuta A; Nowowiejska B
    Rocz Akad Med Bialymst; 1995; 40(3):619-24. PubMed ID: 8775316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
    Luther P; Brachmann I; Werchan D; Wittig C; Tischner H
    Z Erkr Atmungsorgane; 1990; 175(2):95-9. PubMed ID: 2264367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience with the use of IRS-19 for the rehabilitation of children after acute respiratory infections].
    Mukhomedzianova LV; Andriianova IV; Kashirtseva IA
    Vestn Otorinolaringol; 2012; (2):61-2. PubMed ID: 22810641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of bacterial respiratory infection by a new vaccine, an association of bacterial ribosomes and membranous adjuvants. 1. General remarks.
    Michel FB; Dussourd d'Hinterland L
    Arzneimittelforschung; 1980; 30(1a):196-8. PubMed ID: 6892779
    [No Abstract]   [Full Text] [Related]  

  • 15. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
    Macchi A; Vecchia LD
    Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of infections in chronic bronchitis using vaccination and/or immunomodulation].
    Latil F; Arnaud A; Lagier F; Charpin J; Vervloet D
    Rev Mal Respir; 1988; 5(1):31-5. PubMed ID: 3368632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broncho-vaxom in the treatment and prophylaxis of recurrent respiratory tract infections in bronchial asthma.
    Chyrek-Borowska S; Moniuszko T; Szymański W; Rogalewska A
    Pneumonol Alergol Pol; 1992; 60 Suppl 2():117-9. PubMed ID: 1305486
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation trial of respiratory bacterial prophylaxis by a ribosomal vaccine. Multicentric double blind study.
    Fumex JP; Michel FB
    Arzneimittelforschung; 1980; 30(1a):206-13. PubMed ID: 6989376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines].
    Kapellerová A; Sulko M; Krovinová A; Jakubovská M; Michalicková J; Mazáriková O
    Cesk Pediatr; 1989 Aug; 44(8):454-8. PubMed ID: 2791096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic stimulation in prevention of bacterial respiratory infection. Trial objective evaluation by changes in serum and sputum Ig(A and G)].
    Michel FB; d'Hinterland LD; Pinel AM; Guendon R; Guerrero A; Préault M
    Nouv Presse Med; 1975 Feb; 4(5):333-6. PubMed ID: 1093123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.